IPL vs. Q-Switched Lasers for Solar Lentigines: What the Physics Actually Predicts

Solar lentigines, the flat brown patches most people call age spots, are among the most commonly treated pigment lesions in dermatology. Two device families dominate the conversation: intense pulsed light, usually shortened to IPL, and Q-switched lasers, a category that includes the 532 nm and 1064 nm Nd:YAG, the 755 nm alexandrite, and the 694 nm ruby. Patients often assume these machines are interchangeable. Mechanically, they are not, and the differences explain most of the variation in results, downtime, and risk.

The shared target: melanin in a thin layer of skin. A solar lentigo is not a deep structure. The excess pigment sits in the epidermis, produced by melanocytes that have been chronically stimulated by ultraviolet exposure. Any light-based treatment works through selective photothermolysis: deliver energy at a wavelength melanin absorbs, in a pulse short enough that heat stays confined to the pigmented cells rather than spreading into surrounding tissue. Where IPL and Q-switched lasers diverge is pulse duration, and that single variable changes almost everything.

How IPL works. IPL is not a laser. It is a flashlamp that emits a broad spectrum of light, typically 500 to 1200 nm, filtered down to a working band. Pulse durations run in the millisecond range, thousands of times longer than a Q-switched pulse. That longer pulse heats melanin more gently and diffusely. Clinically, a treated lentigo darkens over one to two days, forms a fine crust often described as coffee grounds, and flakes off within a week to ten days. Because the energy is spread across a large spot size and a broad spectrum, IPL is efficient for treating a whole cheek or the backs of both hands with scattered spots, and it simultaneously addresses redness from dilated vessels, which lasers tuned purely for pigment do not.

How Q-switched lasers work. Q-switching compresses laser output into nanosecond pulses. At that speed, energy deposits into melanosomes faster than heat can diffuse out, creating a photoacoustic effect: the pigment granules are effectively shattered rather than slowly cooked. The immediate endpoint is characteristic, a transient ash-white frosting on the spot. Fragmented pigment is then cleared by the immune system and shed with epidermal turnover over one to two weeks. Newer picosecond lasers push the same principle further with even shorter pulses, favoring mechanical breakup over heat and, in principle, reducing thermal injury to surrounding skin.

Effectiveness, compared honestly. Head to head studies on solar lentigines generally find that Q-switched and picosecond lasers clear individual spots more completely in fewer sessions, often one to two treatments for a discrete lesion versus two to four IPL sessions. The tradeoff is precision versus coverage. A laser excels at a handful of well-defined spots. IPL excels at diffuse photodamage, where dozens of faint lentigines blend with background mottling and redness. Many clinicians use both across a treatment plan rather than treating the choice as either or.

The risk profile is where skin tone decides. Melanin absorption does not distinguish between the pigment in a lentigo and the pigment in surrounding normal skin. In deeper skin tones, Fitzpatrick types IV to VI, both technologies carry meaningful risk of post-inflammatory hyperpigmentation, where the treated area heals darker than before, and hypopigmentation, where it heals lighter. IPL is generally considered riskier in darker skin because its broad spectrum includes shorter wavelengths that background melanin absorbs strongly. Among lasers, the 1064 nm Q-switched Nd:YAG penetrates deeper and is absorbed less avidly by epidermal melanin, which is why it is often the preferred wavelength when treating pigment in darker skin, though results on flat lentigines at 1064 nm are typically more gradual. Picosecond devices with fractionated handpieces are also studied in this context for similar reasons.

A caution that applies to both machines. Not every flat brown spot is a lentigo. Lentigo maligna, an early form of melanoma, can look remarkably similar to a benign age spot, and treating it with light-based devices can blur the clinical picture without addressing the malignancy. Any spot that is new, changing, irregular in border or color, or simply uncertain should be evaluated, and sometimes biopsied, before any cosmetic treatment. This step matters more than the device choice.

Recurrence is about biology, not device failure. Neither IPL nor a laser removes the melanocytes' tendency to overproduce pigment under ultraviolet stimulation. Spots recur in a substantial fraction of patients within a year or two without strict photoprotection. Daily broad spectrum sunscreen, and for many patients a maintenance topical such as a retinoid or azelaic acid, does more to preserve results than upgrading from one device to another.

The bottom line. For a few discrete lentigines on lighter skin, a Q-switched or picosecond laser usually clears them fastest. For diffuse sun damage with mixed pigment and redness, IPL covers more ground per session. For deeper skin tones, wavelength selection and conservative settings matter more than the technology category, and 1064 nm approaches are often favored. In every case, confirm the diagnosis first and protect the result afterward.